Pfizer CEO: Vaccine third dose ‘likely’ needed within 12 months

Pfizer published a study earlier this month that said its jab is more than 91% effective at protecting against the coronavirus, and more than 95% effective against severe cases of COVID-19 up to six months after the second dose.

Read the full story: Read More